Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Eeshan Khandekar"'
Reflections on Sharing Clinical Trial Data : Challenges and a Way Forward: Proceedings of a Workshop
Autor:
National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Health Care Services, Board on Health Sciences Policy, Roundtable on Genomics and Precision Health, National Cancer Policy Forum, Forum on Neuroscience and Nervous System Disorders, Forum on Drug Discovery, Development, and Translation, Carolyn Shore, Jennifer Hinners, Eeshan Khandekar, Theresa Wizemann
On November 18 and 19, 2019, the National Academies of Sciences, Engineering, and Medicine hosted a public workshop in Washington, DC, titled Sharing Clinical Trial Data: Challenges and a Way Forward. The workshop followed the release of the 2015 Ins
Autor:
National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Health Sciences Policy, Forum on Drug Discovery, Development, and Translation, Carolyn Shore, Eeshan Khandekar, Joe Alper
Successful drug development relies on accurate and efficient clinical trials to deliver the best and most effective pharmaceuticals and clinical care to patients. However, the current model for clinical trials is outdated, inefficient and costly. Cli
Autor:
Abdul-Wahid Al-Mafazy, Abdullah S. Ali, Joseph R. Egger, Eeshan Khandekar, Humphrey R. Mkali, Randall A. Kramer, Michael V. Mckay, Sara LeGrand, Jeremiah Ngondi
Publikováno v:
The American Journal of Tropical Medicine and Hygiene. 100:256-263
As countries transition toward malaria elimination, malaria programs rely on surveillance–response systems, which are often supported by web- and mobile phone–based reporting tools. Such surveillance–response systems are interventions for elimi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac5b1a7ce16620a74b2aa3b05a7b8e79
https://doi.org/10.4269/ajtmh.17-0546
https://doi.org/10.4269/ajtmh.17-0546
Autor:
Eeshan Khandekar, John A. Wagner, Lynn D. Hudson, Joseph A. DiMasi, Steven K. Galson, Christopher P. Austin, Robert M. Califf
Publikováno v:
Nature Reviews Drug Discovery. 20:259-260
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67cbcf61878be1d2a212b8e5f1aa1ca5
https://doi.org/10.1038/d41573-020-00167-0
https://doi.org/10.1038/d41573-020-00167-0
Successful drug development relies on accurate and efficient clinical trials to deliver the best and most effective pharmaceuticals and clinical care to patients. However, the current model for clinical trials is outdated, inefficient and costly. Cli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4974ee7d614927dc8fe1e71ece0294f0
https://doi.org/10.17226/25502
https://doi.org/10.17226/25502
Autor:
National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Health Sciences Policy, Roundtable on Genomics and Precision Health, Forum on Drug Discovery, Development, and Translation, Carolyn Shore, Sarah H. Beachy, Anna Nicholson, Siobhan Addie, Meredith Hackmann, Eeshan Khandekar
On March 24, 2020, a 1-day public workshop titled The Role of Digital Health Technologies in Drug Development was convened by the National Academies of Sciences, Engineering, and Medicine. This workshop builds on prior efforts to explore how virtual